CompoAtlas

Ginkgo Biloba - 30 gélules

Food supplement declared in France, decision dated 24 January 2025

Ginkgo Biloba - 30 gélules (NUPREVA Laboratoire) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Ginkgo biloba 120 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
NUPREVA Laboratoire
Food business operator placing the product on the market
Nupreva laboratoire
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 gélule par jour
Directions for use
Prendre 1 gélule le matin avec un verre d’eau.
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking anticoagulants, Taking antidepressants, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Memory, Concentration

Declaration 5093, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Ginkgo biloba L.FeuilleExtrait sec hydroalcoolique120 mg

Other ingredients

Acacia seyal Delile

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Complément alimentaire réservé à l’adulte. Ne pas dépasser la dose journalière recommandée. Déconseillé chez la femme enceinte, allaitante, chez les enfants, en cas d’épilepsie, en cas de prise simultanée de traitement anticoagulant, antidépresseurs et en cas d’acte interventionnel invasif programmé. En cas de traitements médicamenteux, demander conseil à un professionnel de santé. Tenir hors de la portée des enfants. A consommer avec une alimentation variée et équilibrée et un mode de vie sain. A conserver dans un endroit frais, sec et à l’abri de la lumière.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba L.
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : NUPREVA Laboratoire

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ginkgo Biloba - 30 gélules (NUPREVA Laboratoire): composition and regulation”, https://compoatlas.com/en/supplements/products/5093-ginkgo-biloba-30-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line